{"nct_id":"NCT01844765","title":"Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2013-08-20","start_date_type":"ACTUAL","primary_completion_date":"2016-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}